BioGaia AB (publ)
STO: BIOG-B.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Theresa Agnew
- Employees
- 224
- Headquarters
- Stockholm, Sweden
- IPO year
- 2000
- Market cap
- SEK 12.7B
- Website
- https://www.biogaia.com
Loading BIOG-B…
Loading profile data…Frequently asked questions about BIOG-B
What does BioGaia AB (publ) (BIOG-B.ST) do?
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Ad...
Where does BIOG-B.ST trade?
BioGaia AB (publ) (BIOG-B.ST) trades on the Stockholm Stock Exchange.
What sector is BIOG-B.ST in?
BioGaia AB (publ) (BIOG-B.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BioGaia AB (publ)?
Theresa Agnew is the chief executive officer of BioGaia AB (publ) (BIOG-B.ST).
Where is BioGaia AB (publ) headquartered?
BioGaia AB (publ) is headquartered in Sweden.
Does BIOG-B.ST pay a dividend?
Yes — BioGaia AB (publ) (BIOG-B.ST) paid a trailing twelve-month dividend of SEK 4.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIOG-B.ST go public?
BioGaia AB (publ) (BIOG-B.ST) completed its initial public offering in 2000.